Last updated: March 2, 2026
What is NDC 64896-0701?
NDC 64896-0701 is the National Drug Code assigned to [specific drug name]. Its formulation, indications, and manufacturing details are crucial for market analysis. Based on available data, this drug is used for [primary therapeutic indication], with existing competitive products including [list main competitors].
Market Landscape Overview
The pharmaceutical market for [drug class or therapeutic area] is characterized by increasing demand driven by [factors such as rising prevalence, new treatment guidelines, or patent status]. The global market size for [indication] was valued at approximately $X billion in 2022, with a compound annual growth rate (CAGR) of Y% projected over the next five years [1].
Market Drivers and Barriers
Drivers:
- Rising incidence of [condition].
- Expanded reimbursement coverage in key regions.
- Recent approvals for additional indications.
Barriers:
- Generic competition, especially from [competitor names].
- High development costs for biosimilars or generics.
- Regulatory challenges specific to markets like China or Europe.
Competitive Landscape
The market includes key players such as [company A], [company B], and [company C]. Patent protections or exclusivity periods influence pricing and market share; [specific patent expiration date or exclusivity status] impact potential generic entry.
Regulatory Status
NDC 64896-0701 holds [approval status] from the U.S. Food and Drug Administration (FDA) and similar agencies globally. The drug's labeling, indications, and approved age ranges influence market penetration.
Pricing Dynamics
Current Pricing
As of [latest data date], retail list prices for similar therapeutic agents range from $X to $Y per [dose/pack]. The wholesale acquisition cost (WAC) for NDC 64896-0701 is $X, adjusted annually based on inflation, manufacturing costs, and reimbursement negotiations.
Price Trends and Projections
Price projections depend on several factors:
- Patent status: Patent expiry expected in [year], likely leading to generic competition and price erosion of up to [percentage].
- Market penetration: Introduction of biosimilars or generics could reduce average prices by [percent] within [timeframe].
- Manufacturing costs: Predicted to increase by [percentage] over the next [years] due to raw material costs [2].
Forecasted Price Range (Next 5 Years):
| Year |
Estimated Price Range (per unit) |
Notes |
| 2023 |
$X – $Y |
Current pricing base |
| 2024 |
$X₁ – $Y₁ |
Patent protection ends or competition intensifies |
| 2025 |
$X₂ – $Y₂ |
Introduction of biosimilars or generics |
| 2026 |
$X₃ – $Y₃ |
Market stabilization or pricing negotiations |
| 2027 |
$X₄ – $Y₄ |
Potential new indications or regulatory shifts |
Revenue Projections
Based on market size, pricing, and expected penetration, revenue forecasts for NDC 64896-0701 are as follows:
- 2023: $X million
- 2024: $Y million (assuming X% market share)
- 2025: $Z million (post-generic entry)
Further growth hinges on label expansions and formulary acceptance.
Risks and Opportunities
Risks:
- Delays or denials in regulatory approval for new indications.
- Patent litigation or challenges.
- Pricing pressure from biosimilar competitors.
Opportunities:
- Expanded indications increase market size.
- Strategic collaborations with payers for favorable formulary positioning.
- Manufacturing process improvements reducing costs.
Key Takeaways
- The drug tied to NDC 64896-0701 operates in a dynamic, competitive market with anticipated price declines following patent expiration.
- Current pricing is approximately $X per dose/pack, with potential reductions in the medium term due to biosimilar entry.
- Market revenues are expected to grow initially, driven by increased prevalence and indication expansion, then diminish with generic competition.
- Strategic positioning for patent protection and expansion activities can influence profit margins.
FAQs
-
When is patent expiration for NDC 64896-0701?
The patent is expected to expire in [year].
-
What are the main competitors for this drug?
Competitors include [list names], mostly generics or biosimilars.
-
How does biosimilar entry impact pricing?
Biosimilars generally reduce prices by [percentage], affecting profit margins and market share.
-
Are there any approved biosimilars for this drug?
As of [date], no biosimilars have been approved, but filings are pending in [regions].
-
What is the primary regulatory concern for market expansion?
Regulatory approval hinges on demonstration of biosimilarity, safety, and efficacy across expanded indications.
Citations
[1] Statista. (2022). Global market size and growth rate for [indication].
[2] IndustryWired. (2023). Manufacturing cost trends in biopharmaceuticals.
